Hidden compliance risk is where healthcare returns evaporate. ChronoProof turns it into alpha.
How 
was conceived — and how a five-product suite evolved to turn healthcare regulatory, cybersecurity, and diligence complexity into a repeatable advantage for venture capital.
existsHealthcare VCs were being forced to price compliance risk by feel.
The problem was never a lack of concern. It was a lack of structured intelligence. Firms had fragmented consultant reports and founder assurances, but no continuous way to translate healthcare compliance and cyber complexity into signals they could compare across companies and use across the life of an investment.
exists to make those risks visible, comparable, and actionable across the entire investment lifecycle.
Our Founder spent 25+ years inside the exact risk environment healthcare VCs struggle to underwrite.
Matthew didn't arrive as a generic software founder. He came after decades inside healthcare governance, risk, compliance, security assurance, and AI governance — spanning HIPAA, HITRUST, FDA, NIST, ISO, PCI-DSS, GDPR, and emerging AI risk frameworks.
"Most GRC tools were built for compliance teams. was built for investors — by someone who has sat in the middle of healthcare audits, cloud security certification programs, and AI risk policy, and who understands how those realities impact fund math."
Promising companies looked fine on the pitch deck — and hid risk underneath.
Risk surfaced too late
Unresolved HIPAA, HHS 405(d), FDA, and ISO 14971/13485 exposure appeared in diligence, in enterprise procurement, or at exit — when it was most expensive to fix.
No comparable signal
VCs priced risk with fragmented reports, gut feel, and one-off consultants — not a scalable model in a sector with rising deal flow and tightening compliance expectations.
A data & workflow gap
The real gap wasn't missing software. Investors had no way to continuously convert messy compliance reality into structured signals usable across sourcing, selection, and portfolio management.
The founding thesis: if healthcare compliance and cyber data can be made continuous, comparable, and embedded into VC workflows, then investors can turn a historic pain point into a competitive advantage.
The suite was built in the order investors encounter risk.
Rather than one product, Matthew assembled a team to build a sequence of tools that follow the VC lifecycle — making compliance knowable at the company level, comparable across a portfolio, and finally economic at the fund level.
ChronoTruth
Nothing else works without a foundation. turns messy healthcare compliance obligations into structured evidence, controls, risk signals, and remediation roadmaps — purpose-built for healthcare and medical-device portfolio companies and their Azure environments.
ChronoSee
Layered on to give VCs a fast, recurring, standardized view of cybersecurity posture using the HHS 405(d) framework across all 10 critical domains — a comparable cyber signal across the whole portfolio instead of scattered technical conversations.
ChronoPulse
Data becomes strategic when it can be aggregated, visualized, and explained. turns operating compliance and cyber data into Power BI dashboards, risk simulations, gap analysis, maturity trends, and LP-ready reporting.
ChronoScout
With back-end intelligence in place, the team moved to sourcing. ChronoScout is an AI diligence engine that compresses evaluation from 30+ hours to ~2, expands throughput, and produces 45-page investment memoranda with six-category risk scoring — so VCs look at more opportunities without giving up rigor.
ChronoCurve
ChronoCurve completes the suite where the fund's return is actually decided: the exit. It helps healthcare VCs answer the two hardest questions — when to sell, and for how much — pairing AI-powered timing signals (market comparables, growth trajectory, fund life, and M&A windows) with a triangulated valuation across ARR multiples, DCF, and market benchmarks. Every output is a board-ready recommendation with auditable, citation-backed reasoning, deployed privately in the fund's own Azure environment.
An InfoaaS layer for healthcare venture capital.
Successful information-as-a-service companies sell a proprietary lens on reality: they collect specialized data, normalize it, and feed it back into decisions in a way generic SaaS can't. follows that playbook.
Domain-specific data spine
Ingests healthcare frameworks (HIPAA, HITRUST, FDA 524B, HHS 405(d), ISO 13485/14971, ICH Q9, EU MDR) and Azure configurations, then standardizes them into risk scores, maturity curves, and remediation maps.
Continuous, not one-off
Instead of episodic diligence reports, the platform runs as a continuous layer: quarterly cyber assessments, living compliance roadmaps, fund dashboards, and fund-trajectory modeling.
Embedded in VC workflow
The suite lines up directly against investment stages — screening, onboarding, monitoring, analytics, and fund-performance framing — institutionalizing how firms understand and act on healthcare risk.
Strong funding meets tighter scrutiny — and VCs are caught in the middle.
Healthtech is in a period of strong funding, higher valuations, and growing exits — alongside increased regulatory scrutiny and cyber risk. VCs are under pressure to show more governance discipline to LPs while still increasing throughput and speed. makes that tension manageable.
Evaluate more, dilute nothing
Look at more healthcare deals with deeper diligence — without hiring a full internal GRC team.
Certification-ready portfolios
Move companies toward stronger compliance maturity with clear roadmaps, not ad-hoc heroics.
Evidence-based LP reporting
Report to LPs using hard evidence about governance, cybersecurity, and risk reduction — not narratives alone.
A common language for risk
Regulatory, cyber, and operational readiness become measurable and comparable across the portfolio.
Sell at the right time, for the right number
With ChronoCurve, exit timing and valuation stop being gut calls — they become AI-supported, board-ready recommendations backed by auditable reasoning.
Governance as a source of competitive advantage — not a source of surprises.
" exists because healthcare VCs kept losing money in the same blind spot: compliance and cybersecurity they couldn't see clearly. After 25 years building governance systems for Fortune 500s companies, I assembled a team to turn that expertise into a venture-scale intelligence layer — one that runs from first-look diligence all the way to the exit decision — so investors can finally treat compliance as an advantage, not just a cost."